Anti-Tumour Effects of Bisphosphonates - What have we Learned from In Vivo Models?

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|9|7|807-823

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.9, Iss.7, 2009-11, pp. : 807-823

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Myc - What We have Learned from Flies

By  

Current Drug Targets, Vol. 10, Iss. 7, 2009-07 ,pp. : 590-601

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Non-Steroidal Anti-Inflammatory Drugs: What we have Learned from Animal Studies

By  

Current Drug Targets. Inflammation & Allergy, Vol. 3, Iss. 1, 2004-03 ,pp. : 43-61

Bentham Science Publishers

Access to resources Recommend Favorite

Developing a vaccine against congenital CMV infection: what have we learned from animal models? Where should we go next?

By Schleiss Mark R  

Future Virology, Vol. 8, Iss. 12, 2013-12 ,pp. : 1161-1182

Future Medicine

Access to resources Recommend Favorite

CCR1 Antagonists: What Have We Learned From Clinical Trials

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 13, 2010-09 ,pp. : 1268-1277

Bentham Science Publishers

Access to resources Recommend Favorite

Dictyostelium genomics: how it developed and what we have learned from it

By Noegel A. A.   Glöckner G.  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 68, Iss. 7, 2013-07 ,pp. : 474-477

Govi-Verlag

Access to resources Recommend Favorite